Use of Enalapril to Prevent Myointimal Hyperplasia in Upper Extremity Arteriovenous Fistula for Hemodialysis Access: A Descriptive, Longitudinal, Cross-sectional, Case-control Study

This division aims to evaluate the effect of Enalapril in forbiding Myointimal Hyperplasia (MIH) in arm’s arteriovenous fistula (AVF) for hemodialysis access. The current explanatory, longitudinal, cross-divided case-control study was carried out in our emergency room by the vascular abscission service as one with the radiology duty from January to May of 2017. In our study main causes of early AVF thrombosis, were diabetes and alive smoking; likewise presenting greater MIH within those victims. Our findings on Enalapril as a risk determinant for MIH are inconclusive, still patients in the Enalapril group had lower myointimal complex calculations and less AVF early failure.

Author(s) Details:

Javier Ismael Hernández-Vázquez,
PueblaMed Medical Group in Puebla, Mexico.

Héctor Bizueto-Rosas,
Vascular Surgery and Angiology Department, Specialties Hospital, “La Raza” National Medical Center, Mexican Institute of Social Security, México City, México.

Pablo Martín Boada Sandoval,
Vascular Surgery and Angiology Department, Specialties Hospital, “La Raza” National Medical Center, Mexican Institute of Social Security, México City, México.

Please see the link here: https://stm.bookpi.org/CIMMS-V10/article/view/8864

Keywords: Myointimal hyperplasia, arteriovenous fistula, Enalapril, hemodialysis